ATE506051T1 - Verwendung von furanalkylen zur kosmetischen behandlung von zellulitis - Google Patents

Verwendung von furanalkylen zur kosmetischen behandlung von zellulitis

Info

Publication number
ATE506051T1
ATE506051T1 AT05773029T AT05773029T ATE506051T1 AT E506051 T1 ATE506051 T1 AT E506051T1 AT 05773029 T AT05773029 T AT 05773029T AT 05773029 T AT05773029 T AT 05773029T AT E506051 T1 ATE506051 T1 AT E506051T1
Authority
AT
Austria
Prior art keywords
radical
furanalkylene
cellulitis
cosmetic treatment
alcynyl
Prior art date
Application number
AT05773029T
Other languages
English (en)
Inventor
Antoine Piccirilli
Philippe Msika
Nathalie Piccardi
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0405782A external-priority patent/FR2870742B1/fr
Priority claimed from FR0502756A external-priority patent/FR2870740B1/fr
Application filed by Expanscience Lab filed Critical Expanscience Lab
Application granted granted Critical
Publication of ATE506051T1 publication Critical patent/ATE506051T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
AT05773029T 2004-05-28 2005-05-27 Verwendung von furanalkylen zur kosmetischen behandlung von zellulitis ATE506051T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0405782A FR2870742B1 (fr) 2004-05-28 2004-05-28 Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale
FR0502756A FR2870740B1 (fr) 2005-03-21 2005-03-21 Utilisation d'alkyle furannes pour le traitement cosmetique de la cellulite
PCT/FR2005/001311 WO2005117827A1 (fr) 2004-05-28 2005-05-27 Utilisation d’alkyle furannes pour le traitement cosmetique de la cellulite

Publications (1)

Publication Number Publication Date
ATE506051T1 true ATE506051T1 (de) 2011-05-15

Family

ID=34978609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05773029T ATE506051T1 (de) 2004-05-28 2005-05-27 Verwendung von furanalkylen zur kosmetischen behandlung von zellulitis

Country Status (6)

Country Link
US (1) US7872043B2 (de)
EP (1) EP1753391B1 (de)
AT (1) ATE506051T1 (de)
DE (1) DE602005027563D1 (de)
MX (1) MXPA06013884A (de)
WO (1) WO2005117827A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889956B1 (fr) * 2005-08-30 2012-04-20 Expanscience Lab Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant
ITMI20061522A1 (it) * 2006-08-01 2008-02-02 Difass S A Composizione ad attivita' antiossidante ed antiglicante migliorata
WO2010065528A2 (en) * 2008-12-02 2010-06-10 Kreations By Kristin, L.C. Gymnema-containing lip balm compositions and associated methods
FR2949044B1 (fr) 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127592A (en) * 1977-03-31 1978-11-28 Polak's Frutal Works, B.V. Process of the preparation of hydroxyfurenones
IL63632A (en) 1980-08-27 1986-02-28 Merrell Dow Pharma Acylated furanyl and thienyl acrylic acids and process for their preparation
EP0110548B1 (de) 1982-10-29 1987-06-24 Plessey Overseas Limited Elektrisch leitende Dichtungen
FR2678632B1 (fr) 1991-07-03 1994-09-02 Pharmascience Lab Procede de preparation de l'insaponifiable d'avocat permettant d'ameliorer sa teneur en l'une de ses fractions dite h.
FR2678614A1 (fr) 1991-07-03 1993-01-08 Pharmascience Lab Compose presentant une activite en tant qu'inhibiteur de la collagenase et medicament le contenant.
US5468490A (en) * 1993-10-25 1995-11-21 Conkle & Olesten Lipidic furans useful for skin therapeutics
KR980009257A (ko) 1996-07-02 1998-04-30 주상섭 2-히드록시프로피온산 유도체 및 그의 제조방법
DE19901502C1 (de) 1999-01-11 2000-09-21 Michael Schneider Anticellulitiszusammensetzung und ihre Verwendung
FR2798667B1 (fr) 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
ATE509014T1 (de) 2001-01-26 2011-05-15 Chugai Pharmaceutical Co Ltd Malonyl coa-decarboxylase inhibitoren als stoffwechselmodulatoren
US20030120073A1 (en) 2001-04-25 2003-06-26 Seto Christopher T. Alpha-ketocarboxylic acid based inhibitors of phosphoryl tyrosine phosphatases
JP2005232005A (ja) 2001-07-02 2005-09-02 Maruha Corp 新規脂肪族化合物、合成方法、利用方法
AU2002322585A1 (en) 2001-07-20 2003-03-03 Adipogenix, Inc. Fat accumulation-modulating compounds
WO2003048316A2 (en) * 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Polynucleotides encoding novel human mitochondrial and microsomal glycerol-3-phosphate acyl-transferases and variants thereof
US7985771B2 (en) * 2002-01-31 2011-07-26 Monsanto Technology Llc Furanone derivatives
FR2841470B1 (fr) 2002-06-27 2006-01-13 Pharmascience Lab Utilisation d'isoflavones pour la preparation de compositions topiques utiles pour favoriser l'amincissement et methode de traitement cosmetique associee
WO2004016106A1 (fr) 2002-07-29 2004-02-26 Laboratoires Expanscience Procede d'obtention d'un insaponifiable d'avocat riche en lipides furaniques
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
US20050048144A1 (en) 2003-08-29 2005-03-03 Xiao-Qing Han Herb extract-based cosmeceutical cream for controlling the blood sugar level of diabetes and methods for making it

Also Published As

Publication number Publication date
EP1753391A1 (de) 2007-02-21
MXPA06013884A (es) 2007-01-26
DE602005027563D1 (de) 2011-06-01
WO2005117827A1 (fr) 2005-12-15
US7872043B2 (en) 2011-01-18
US20070281994A1 (en) 2007-12-06
EP1753391B1 (de) 2011-04-20

Similar Documents

Publication Publication Date Title
DE602004012079D1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
NO20052993L (no) 4,5-diaryltiazolderivater som CB-1 ligander.
DE69911210D1 (de) Verwendung von piperin und derivate davon zur behandlung von hautpigmentierungstörungen und hautkrebs
BG105395A (en) Benzocyclohexandiones, method for the production and use thereof as herbiicides and plant growth regulators
ATE525067T1 (de) Amino-substituierte (e)-2,6-dialkoxystyryl 4- substituierte benzylsulfone zur behandlung von proliferierenden erkrankungen
ATE279921T1 (de) Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache
ATE389382T1 (de) Zusammensetzungen enthaltend amidine und alkan polyol
ATE361752T1 (de) Methoden zur prophylaxe und behandlung von schäden der wahrnehmungshärchenzellen und der cochlearen neuronen
ATE347401T1 (de) Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite
DE602005020274D1 (de) Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht
ATE271865T1 (de) Verwendung von cholinesterasehemmern zur behandlung von aufmerksamkeitsmangel-störungen
DE602005027563D1 (de) Verwendung von furanalkylen zur kosmetischen behandlung von zellulitis
ATE353667T1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
FR2718137B1 (fr) Procédé de préparation de trialcoylsilyl-7 baccatine III.
WO2011032762A3 (de) Schonende färbe- und aufhellmittel mit verbesserter aufhellleistung
MA32976B1 (fr) Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique comme activateurs de hif
ATE294784T1 (de) Verwendung von benzotriazolen als uv-absorber
MXPA05004845A (es) N-oxidos y derivados de melfalan para el tratamiento de estados de enfermedad asociados a un factor inducible por hipoxia.
HUP0302408A2 (hu) Új aminotriazolon-vegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
ATE325599T1 (de) Verwendung von ectoin und ectoinderivaten zur behandlung von haaren
ATE211903T1 (de) Verwendung von n-aryl-2-hydroxyalkylamiden zur induzierung und/oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls
ATE419238T1 (de) Arylsulfanyl und heteroarylsulfanyl-derivate zur behandlung von schmerz
DE502004005795D1 (de) Verwendung von peptiden zum schutz der haut vor haarbehandlungsmitteln
DE69418689D1 (de) Nitrone verwendbar zum abfangen von freien radikalen
ATE380551T1 (de) Verwendung von brimonidine zur behandlung von dementia und morbus parkinson

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties